Raja Mudad

583 total citations
35 papers, 435 citations indexed

About

Raja Mudad is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Raja Mudad has authored 35 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 7 papers in Genetics. Recurrent topics in Raja Mudad's work include Lung Cancer Treatments and Mutations (13 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Lung Cancer Research Studies (10 papers). Raja Mudad is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Lung Cancer Research Studies (10 papers). Raja Mudad collaborates with scholars based in United States, Japan and France. Raja Mudad's co-authors include William H. Kane, Wungki Park, Marilyn J. Telen, Chukwuemeka Ikpeazu, N A Rao, William P. Peters, Atif Hussein, Arnold Alper, Gilberto Lopes and Gilberto Lopes and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Raja Mudad

35 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raja Mudad United States 15 174 133 107 79 46 35 435
Lola Luo United States 8 113 0.6× 69 0.5× 164 1.5× 61 0.8× 62 1.3× 8 403
Donna Bucci United States 10 97 0.6× 64 0.5× 129 1.2× 48 0.6× 26 0.6× 18 319
Manali Rupji United States 13 165 0.9× 111 0.8× 59 0.6× 77 1.0× 76 1.7× 45 479
Shou Ching Tang Canada 6 200 1.1× 66 0.5× 177 1.7× 103 1.3× 14 0.3× 7 506
Masako Uno Japan 12 148 0.9× 87 0.7× 72 0.7× 38 0.5× 57 1.2× 38 528
Said Baidas United States 12 142 0.8× 125 0.9× 89 0.8× 23 0.3× 38 0.8× 22 442
Alexander B. Sibley United States 12 171 1.0× 80 0.6× 100 0.9× 43 0.5× 71 1.5× 27 393
Isabella Sassi Italy 12 178 1.0× 99 0.7× 125 1.2× 78 1.0× 48 1.0× 31 622
Ying A. Wang United States 9 196 1.1× 128 1.0× 40 0.4× 105 1.3× 46 1.0× 11 417
Derui Li China 15 121 0.7× 200 1.5× 37 0.3× 40 0.5× 68 1.5× 43 522

Countries citing papers authored by Raja Mudad

Since Specialization
Citations

This map shows the geographic impact of Raja Mudad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raja Mudad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raja Mudad more than expected).

Fields of papers citing papers by Raja Mudad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raja Mudad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raja Mudad. The network helps show where Raja Mudad may publish in the future.

Co-authorship network of co-authors of Raja Mudad

This figure shows the co-authorship network connecting the top 25 collaborators of Raja Mudad. A scholar is included among the top collaborators of Raja Mudad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raja Mudad. Raja Mudad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Wungki, Laura Mezquita, Naoyuki Okabe, et al.. (2019). Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancer. British Journal of Cancer. 122(3). 340–347. 20 indexed citations
2.
Lam, Vincent K., David S. Hong, John V. Heymach, et al.. (2018). Safety and anti-tumor effects of MAGE-A10c796 TCR T-cells in two clinical trials. Annals of Oncology. 29. viii731–viii731. 2 indexed citations
3.
Husnain, Muhammad, Wungki Park, Juan Carlos Ramos, et al.. (2018). Complete response to ipilimumab and nivolumab therapy in a patient with extensive extrapulmonary high-grade small cell carcinoma of the pancreas and HIV infection. Journal for ImmunoTherapy of Cancer. 6(1). 66–66. 21 indexed citations
4.
5.
Mudad, Raja, et al.. (2017). Comparative effectiveness and safety of nab-paclitaxel plus carboplatin vs gemcitabine plus carboplatin in first-line treatment of advanced squamous cell non-small cell lung cancer in a US community oncology setting. SHILAP Revista de lepidopterología. 2 indexed citations
6.
Farhat, Fadi, et al.. (2017). The Concept of Biosimilars: From Characterization to Evolution—A Narrative Review. The Oncologist. 23(3). 346–352. 29 indexed citations
7.
8.
Park, Wungki, Deukwoo Kwon, Amrita Desai, et al.. (2017). Developing a Predictive Model for Clinical Outcomes of Advanced Non-Small Cell Lung Cancer Patients Treated With Nivolumab. Clinical Lung Cancer. 19(3). 280–288.e4. 45 indexed citations
9.
Tchekmedyian, Nishan, Raja Mudad, Fernando F. Blanco, et al.. (2017). Longitudinal monitoring of ctDNA EGFR mutation burden from urine correlates with patient response to EGFR TKIs: A case series. Lung Cancer. 108. 22–28. 21 indexed citations
10.
Park, Wungki, Amrita Desai, Fernando Regla Vargas, et al.. (2017). P3.02c-081 Complete Blood Count Parameters as Predictive Factors in Patients with Advanced Non-Small Cell Lung Cancer Treated with Nivolumab. Journal of Thoracic Oncology. 12(1). S1327–S1327. 1 indexed citations
11.
Davies, Angela M., Raja Mudad, James Moon, et al.. (2007). PD3-1-7: Phase II trial of autologous cancer vaccine, CG8123 (GVAX), in patients with advanced bronchioloalveolar carcinoma (BAC): a Southwest Oncology Group Study (S0310).. Journal of Thoracic Oncology. 2(8). S461–S461. 5 indexed citations
12.
Raez, Luis E., Edgardo S. Santos, Raja Mudad, & Eckhard R. Podack. (2005). Clinical trials targeting lung cancer with active immunotherapy: the scope of vaccines. Expert Review of Anticancer Therapy. 5(4). 635–644. 4 indexed citations
13.
Nedzi, Lucien, et al.. (2004). Seizure prophylaxis in patients with brain metastases from solid tumors: Is phenytoin necessary?. Journal of Clinical Oncology. 22(14_suppl). 8186–8186. 1 indexed citations
14.
Alper, Arnold, et al.. (2003). Interferon-Alpha–Induced Focal Segmental Glomerulosclerosis in Chronic Myelogenous Leukemia. American Journal of Clinical Oncology. 26(3). 262–264. 19 indexed citations
15.
Safah, Hana, et al.. (1997). Frequency ofBCL-2/JH translocations in peripheral blood of follicular lymphoma patients. American Journal of Hematology. 55(4). 205–207. 1 indexed citations
16.
Mudad, Raja, Atif Hussein, & William P. Peters. (1995). Guillain-Barre Syndrome Following Autologous Bone Marrow Transplantation. American Journal of Clinical Oncology. 18(2). 167–169. 20 indexed citations
17.
Mudad, Raja, et al.. (1995). Evidence that CDw108 membrane protein bears the JMH blood group antigen. Transfusion. 35(7). 566–570. 22 indexed citations
18.
Mudad, Raja, et al.. (1995). JMH variants: serologic, clinical, and biochemical analyses in two cases. Transfusion. 35(11). 925–930. 15 indexed citations
19.
Mudad, Raja, James J. Vredenburgh, Erik K. Paulson, et al.. (1994). A radiologic syndrome after high dose chemotherapy and autologous bone marrow transplantation, with clinical and pathologic features of systemic candidiasis. Cancer. 74(4). 1360–1366. 3 indexed citations
20.
Mudad, Raja & William H. Kane. (1993). DDAVP in acquired hemophilia a: Case report and review of the literature. American Journal of Hematology. 43(4). 295–299. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lola Luo Breakdown of academic impact, for papers by Donna Bucci Breakdown of academic impact, for papers by Manali Rupji Breakdown of academic impact, for papers by Shou Ching Tang Breakdown of academic impact, for papers by Masako Uno Breakdown of academic impact, for papers by Said Baidas Breakdown of academic impact, for papers by Alexander B. Sibley Breakdown of academic impact, for papers by Isabella Sassi Breakdown of academic impact, for papers by Ying A. Wang Breakdown of academic impact, for papers by Derui Li
Rankless by CCL
2026